Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease.
about
Hepatic late adverse effects after antineoplastic treatment for childhood cancerMicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic ConsiderationsMicroRNAs may solve the mystery of chronic hepatitis B virus infectionAlanine aminotransferase-old biomarker and new concept: a reviewExercise-Induced Release of Pharmacologically Active Substances and Their Relevance for Therapy of Hepatic InjuryRevised cutoff values of ALT and HBV DNA level can better differentiate HBeAg (-) chronic inactive HBV patients from active carriersA panel of serum microRNAs as specific biomarkers for diagnosis of compound- and herb-induced liver injury in ratsAdult mouse model of early hepatocellular carcinoma promoted by alcoholic liver diseaseIncreased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis.Development and validation of a prognostic model for predicting 30-day mortality risk in medical patients in emergency department (ED).Inverse Relationship between Hepatic Steatosis and Alanine Aminotransferase with Sex Hormone-Binding Globulin in MenSerum hepatitis B core antibody as a biomarker of hepatic inflammation in chronic hepatitis B patients with normal alanine aminotransferaseThe inhibitory effect of ethanol on Sestrin3 in the pathogenesis of ethanol-induced liver injuryRisk factors of liver metastasis from advanced pancreatic adenocarcinoma: a large multicenter cohort study.Impacts of common factors of life style on serum liver enzymes.Hepatocyte death: a clear and present danger.Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients.Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease.Apoptosis as a mechanism for liver disease progression.Protein profiling in hepatocellular carcinoma by label-free quantitative proteomics in two west African populationsElevated alanine aminotransferase is strongly associated with incident metabolic syndrome: a meta-analysis of prospective studiesComplex association between alanine aminotransferase activity and mortality in general population: a systematic review and meta-analysis of prospective studies.Age as a predictor of significant fibrosis features in HBeAg-negative chronic hepatitis B virus infection with persistently normal alanine aminotransferaseEffects of aerobic vs. resistance training on visceral and liver fat stores, liver enzymes, and insulin resistance by HOMA in overweight adults from STRRIDE AT/RTChanges in serum alanine aminotransferase levels in telbivudine versus lamivudine treatment for chronic hepatitis B: a meta-analysis.Synergistic association between alcohol intake and body mass index with serum alanine and aspartate aminotransferase levels in older adults: the Rancho Bernardo Study.Recognizing and preventing death from compensated cirrhosis in the communityUpper limits of normal for alanine aminotransferase activity in the United States population.Correlations of IFN-γ-inducible protein-10 with the risk of chronic hepatitis B and the efficacy of interferon therapy in Asians.HIV Infection Status as a Predictor of Hepatitis C Virus RNA Testing in Primary CareIntrahepatic mRNA Expression of FAS, FASL, and FOXP3 Genes Is Associated with the Pathophysiology of Chronic HCV Infection.Evaluating of Physiological Chemical Levels in Blood to Assess the Risk of Morbidity and Mortality of Ischemic Cardiovascular Disease.Serum Fetuin-A Associated With Fatty Liver Index, Early Indicator of Nonalcoholic Fatty Liver Disease: A Strobe-Compliant Article.Lipopolysaccharide mediates immuno-pathological alterations in young chicken liver through TLR4 signalingA wild-type mouse-based model for the regression of inflammation in atherosclerosis.Awareness of the severity of liver disease re-examined using software-combined biomarkers of liver fibrosis and necroinflammatory activity.Biochemical markers of aging for longitudinal studies in humans.Diurnal variation in serum alanine aminotransferase activity in the US populationA Comparison of Uremic Pruritus in Patients Receiving Peritoneal Dialysis and HemodialysisMild Hypertransaminasemia in Primary Care.
P2860
Q24235525-05DB8D00-117E-4723-8CF2-2F443E11A81EQ26773183-38DDC16F-449D-4799-BEE9-5306E3BCA894Q26827668-02D977F2-108A-4834-BB43-88082ECEFFE2Q26828819-592DBE58-18CD-4398-BAFB-FA4DDAA1031DQ28072762-BF069BFA-CFD5-4151-8DE8-ABC019335B94Q28386713-BDA32296-A406-46E1-B2CF-82235BA977F5Q28483810-B5CFBCB2-4E70-48B9-8028-4336BF372976Q28834514-95EFD473-7EBE-4929-A81F-1B6280C59715Q30660817-1FCDA09A-697C-464B-88C6-96B670741F57Q33555539-DB63894E-0314-4FF7-8E6A-1E7D1B39365FQ33734975-0E509630-A49E-4B61-9A56-9641CF56C4B3Q33765826-69A004A6-EF62-4AD4-86E8-F5C4BE050804Q33840005-51456E07-5AF1-4B54-BF3B-2BA9E782F227Q33868592-1AFAF9D8-18C2-4A65-AAA4-0729517BD888Q34137334-EAB24015-4FFC-4636-B844-4D1895D1F8F2Q34147508-E8E94B9B-9C68-41DE-9674-CD55885FB000Q34462246-E32369ED-FCDE-4F8C-B75B-4E95526539AEQ34758973-7E8D22C1-3F46-4B9B-8805-35AF724EEA6EQ34764471-A5EE69D7-22E6-49ED-9BCE-13F51BBB9874Q34918154-4C2184AC-DA07-46CE-8382-335350E4E58EQ35063759-D4FC2A9A-D6DA-4D82-9A67-DB4714646696Q35122003-24DE106E-555A-48EC-A7C5-47D3708932C4Q35464781-3F15B0DF-CA6A-4411-A032-9F4F36A70C68Q35543638-C27C204D-F347-4FAB-9EC4-B3EC95442DCDQ35562322-4647ECB9-C7F8-49EA-AD35-F22E1C8413ABQ35563896-E0660433-D3BB-4538-BB77-6851921AC512Q35612709-01D23E52-5AC8-41FC-91C1-0D5D6A6CDE7AQ35713666-9C0E8FC8-424C-42F3-907E-EA80C6CAD464Q36014403-092822E9-FE6E-4375-8ACF-CC9763DB7918Q36015496-E6F0F358-D46D-4583-9166-949C1AB7D87DQ36034835-9A57C49D-90EB-442C-B564-96D741DC5F48Q36102545-379ABEBF-47E4-4790-BF0F-185C05A3E235Q36195780-D20B135D-2D07-47E5-9398-2E8DB76AA5F8Q36292136-87EBF2F3-954A-4E69-BE1A-32D95DFA185EQ36307611-A0BC46E7-0A1C-4A3F-9C97-4170FDDEDC7CQ36406176-24871364-5794-454E-B138-B836B36AC168Q36449881-E4AD1A61-9623-4789-9B7F-43186085945FQ36532832-9564B9E6-2D93-4A40-A57F-961E2C5B6821Q36664020-3884A962-CE07-44AB-AC36-37F90AF18FD7Q36962095-DD500791-5C37-4544-8E8C-3AF606A38CA9
P2860
Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease.
@en
Serum activity of alanine aminotransferase
@nl
type
label
Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease.
@en
Serum activity of alanine aminotransferase
@nl
prefLabel
Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease.
@en
Serum activity of alanine aminotransferase
@nl
P2093
P356
P1433
P1476
Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease.
@en
P2093
Henry C Bodenheimer
Public Policy Committee of the American Association for the Study of Liver Disease
Steven L Flamm
P304
P356
10.1002/HEP.22109
P407
P577
2008-04-01T00:00:00Z